CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Resat Cinar

ORCID: 0000-0002-8597-7253↗

Public evidence

7 connected articles

Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis2024 · medRxiv CB<sub>1</sub> receptors on a subset of vagal afferent neurons modulate voluntary ethanol intake in mice.2026 · Europe PMC An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis.2023 · Europe PMC Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction.2022 · Europe PMC CB<sub>1</sub> R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome.2021 · Europe PMC Synthetic cannabinoids induce acute lung inflammation <i>via</i> cannabinoid receptor 1 activation.2020 · Europe PMC Dual inhibition of cannabinoid CB<sub>1</sub> receptor and inducible NOS attenuates obesity-induced chronic kidney disease.2020 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Resat Cinar - Medical Cannabis Research Engine